UK Markets close in 8 hrs 22 mins

Vifor Pharma AG (GNHAF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
112.750.00 (0.00%)
At close: 09:54AM EST
Full screen
Trade prices are not sourced from all markets
Previous close112.75
Bid0.00 x 0
Ask0.00 x 0
Day's range112.75 - 112.75
52-week range112.75 - 149.99
Avg. volume38
Market cap7.447B
Beta (5Y monthly)1.30
PE ratio (TTM)18.74
EPS (TTM)6.02
Earnings dateN/A
Forward dividend & yield2.21 (1.67%)
Ex-dividend date10 May 2021
1y target estN/A
  • Business Wire

    Vifor Pharma comments on market speculations

    ST. GALLEN, Switzerland, December 02, 2021--Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Reuters

    Australia's CSL in exclusive talks for $7 billion buyout of Swiss Vifor Pharma - report

    After discussing a potential deal since March, the companies were now in advanced talks and CSL, the world's largest maker of blood plasma treatments, was carrying out due diligence on the Swiss firm, according to reports in The Australian Financial Review and The Australian. Both Vifor Pharma and CSL said in separate statements that they will not comment on the speculation. Morgan Stanley analysts said in a research note that CSL may be seeking diversification because blood plasma collections - where it pays people to give blood, which it then converts to treatments - remained depressed due to COVID-19 restrictions.

  • Business Wire

    Vifor Pharma announces changes to the Executive Committee as CFO retires

    ST. GALLEN, Switzerland, November 30, 2021--Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR